Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × TroVax × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 Thoracic 1 Other solid neoplasm 1 Gynecologic 1 Gastrointestinal 1

Conditions

Recurrence 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 234 Carboplatin 218 Bevacizumab 139 Cisplatin 134 pembrolizumab 88 Gemcitabine 69 olaparib 55 Docetaxel 47 Topotecan 44 Radiotherapy 43 liposomal doxorubicin 42 Taxes 42 niraparib 38 Cyclophosphamide 36 Doxorubicin 31 Letrozole 28 Drug Therapy 28 Nivolumab 26 Immunoglobulin G 25 Magnetic Resonance Spectroscopy 24 Disulfides 24 Oxaliplatin 23 durvalumab 22 Albumin-Bound Paclitaxel 22 apatinib 21 Etoposide 21 Brachytherapy 21 Filgrastim 20 lenvatinib 19 camrelizumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01556841 2019-05-09

TRIOC

University College, London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡